drugset / Trial / NCT06405204
of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve
RandomizedParallel-groupSingle-blindTreatment
Summary
To evaluate the role of Myo-inositol, melatonin and co-enzyme Q10 on ovarian reserve parameters and ICSI outcome in poor ovarian responder
Timeline
- Start
- 2024-06-30
- Primary completion
- 2024-12-30
- Completion
- 2024-12-30
Outcome
Met primary endpoint
paper CoQ10 markedly improved the oocyte count and peak E2 (p <0.001). PMID 41800295 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coenzyme Q10 | Other / unclassified | 100 mg | — |
| Subject | Melatonin | Small molecule | — | Oral |
| Subject | Myo-inositol | Small molecule | 1 g | — |
| Comparator | folic acid | Other / unclassified | 400 ug | — |
Indications
No indication recorded.